← Eichor
Study identifier: NCT07103291 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Isocapnic Respiratory Muscle Endurance Training in Healthy Adults

Condition: Healthy Adults  ·  Sponsor: University of British Columbia

PhaseNA
Planned participants32
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersYes

About this study

Respiratory muscle training (RMT) strengthens breathing muscles and may improve exercise performance and reduce breathlessness. However, different training methods and devices create controversy in the field. Two main types of RMT exist: inspiratory muscle training (IMT) and respiratory endurance training, like voluntary isocapnic hyperpnea (VIH). While IMT is well-studied, the impact of VIH on breathlessness remains unclear. This study will use the Canadian-developed BreathWayBetter device to examine how 5 weeks of VIH affects breathing discomfort and muscle function. Findings may help personalize RMT for athletes and clinical patients, improving respiratory care and exercise tolerance.

This description comes directly from the study's public registry record.

Talk to the study team

Olivia Ferguson, MSc  ·  604-806-8835  ·  Olivia.Ferguson@hli.ubc.ca

Satvir Dhillon, MSc  ·  604-806-8835  ·  satvir.dhillon@hli.ubc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

St. Paul's HospitalVancouver, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07103291